BSX Financial Facts

Net income (loss) per common share - assuming dilution: 0.17
Intangible asset impairment charges: 7M
See Full Income Statement

See Full Balance Sheet

Boston Scientific (BSX) Earnings

  |   Expand Research on BSX
Next EPS Date 10/28/21 *Est. EPS Growth Rate +400.0% *Last Qtr.
Average EPS % Beat Rate +143.9% Revenue Growth Rate +53.9% *Last Qtr.
Average % Move 1-Wk after EPS +1.5% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/27/21 Q221 $0.40$0.37 +$0.03$3.08B$2.94B = Details
4/28/21 Q121 $0.37$0.31 +$0.06$2.75B$2.62B = Details
10/28/20 Q320 $0.37$0.25 +$0.12$2.67B$2.52B = Details
7/29/20 Q220 $0.08-$0.02 +$0.10$2B$1.73B = Details
4/29/20 Q120 $0.28$0.31 -$0.03$2.54B$2.52B = Details
2/5/20 Q419 $0.46$0.44 +$0.02$2.91B$2.92B = Details
10/23/19 Q319 $0.39$0.38 +$0.01$2.71B$2.65B = Details
7/24/19 Q219 $0.39$0.38 +$0.01$2.63B$2.64B = Details